Penetration of Antibacterials into Bone: What Do We Really Need to Know for Optimal Prophylaxis and Treatment of Bone and Joint Infections?

Author： Pea Federico  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.48, Iss.2, 2009-01, pp. : 125-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

When to use new antibacterials in Gram-positive infections?

By  

Inpharma, Vol. 1, Iss. 1260, 2000-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

What is the Place of Fluoroquinolones in the Treatment of Community-Acquired Respiratory Tract Infections?

By Momméja-Marin H.   Carbon C.  

Drugs, Vol. 57, Iss. 6, 1999-06 ,pp. : 851-853

Adis International

Access to resources Recommend Favorite

Neuropsychiatric Adverse Effects of Mefloquine: What Do We Know and What Should We Do?

By Nosten F.  

CNS Drugs, Vol. 11, Iss. 1, 1999-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

Dilemmas about the toxicological consequences of metal-on-metal hip prostheses - What we do and do not know, and what we should do?

By Brent Jeffrey  

Clinical Toxicology, Vol. 51, Iss. 4, 2013-05 ,pp. : 195-198

Informa Healthcare

Access to resources Recommend Favorite

Optimal Antagonism of the Renin-Angiotensin-Aldosterone System: Do We Need Dual or Triple Therapy?

By Werner Christian   Pöss Janine   Böhm Michael  

Drugs, Vol. 70, Iss. 10, 2010-07 ,pp. : 1215-1230

Adis International

Access to resources Recommend Favorite